NCT05006664
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05006664
Title Brentuximab Vedotin in Combination With CHEP in Patient With PTCL
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Czech Lymphoma Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CZE

Facility Status City State Zip Country Details
University Hospital Brno Brno 625 00 Czechia Details
University Hospital Hradec Králové Hradec Králové 500 05 Czechia Details
University Hospital Olomouc Olomouc 775 20 Czechia Details
University Hospital Ostrava Ostrava 70852 Czechia Details
University Hospital Plzeň Pilsen 323 00 Czechia Details
University Hospital Kralovske Vinohrady Prague 100 00 Czechia Details
Charles University General Hospital Prague 128 08 Czechia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field